Maze Therapeutics

IPO

Harnessing the power of genetics to transform the lives of patients

Maze Therapeutics was founded in 2020, is headquartered in South San Francisco, United States, lists 51–200 employees, and has $305.0M in recorded funding across 2 rounds.

Employees
51–200
Founded
2020
Business Model
Other
Website
mazetx.com
Total Funding
$305.0M
Last Round
$115.0M Series DDec 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Maze Therapeutics is a clinical-stage biopharmaceutical company using human genetics insights via its Compass platform to develop small molecule precision medicines for kidney and metabolic diseases like APOL1-mediated kidney disease and chronic kidney disease.

Summary

Maze Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2020. It lists 51–200 employees. It has raised $305.0M in total across 2 rounds, most recently a $115.0M Series D round in Dec 2024. Investors include Frazier Life Sciences, Deep Track Capital and Matrix Capital Management.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOInitial Public OfferingJan 2025
$140.0M

Sign up to see all 3 events

Funding: Venture Round through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Maze Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/maze-therapeutics"><img src="https://indexed.vc/api/badge/company/maze-therapeutics" alt="Maze Therapeutics on Indexed.vc" width="260" height="76" /></a>